BHIC BioScience Health Innovations, Inc.

OTC Services-Computer Processing & Data Preparation NV CIK: 0001784440
AI RATING
BUY
72% Confidence

Investment Thesis

BHIC demonstrates exceptional profitability with 64.8% gross margins and 21.3% net margins, supported by explosive 208.7% YoY revenue growth. The company maintains a fortress balance sheet with zero debt, $1.1M cash, and strong returns on equity (51.2%) and assets (42.4%), though concerns exist around modest operating cash flow conversion and micro-cap scale.

Strengths

  • + Exceptional gross margin of 64.8% indicates strong pricing power and operational efficiency
  • + Explosive 208.7% YoY revenue growth demonstrates significant market traction and scalability
  • + Outstanding profitability metrics with 21.3% net margin and 51.2% ROE
  • + Zero debt with positive stockholders' equity of $1.7M provides financial flexibility
  • + Massive interest coverage ratio of 1946x indicates no solvency risk

Risks

  • ! Micro-cap company with only $4.1M revenue creates execution risk and limited track record at scale
  • ! Operating cash flow of $272.9K significantly lags net income of $875.7K (31% conversion), raising quality of earnings concerns
  • ! No insider buying activity in last 90 days could indicate limited management confidence
  • ! Minimal current and quick ratio data unavailable, suggesting potential working capital management gaps
  • ! Single period of strong growth requires validation of sustainability in subsequent reporting periods

Key Metrics to Watch

Financial Metrics

Revenue
4.1M
Net Income
875.7K
EPS (Diluted)
$0.08
Free Cash Flow
272.9K
Total Assets
2.1M
Cash
1.1M

Profitability Ratios

Gross Margin 64.8%
Operating Margin 21.3%
Net Margin 21.3%
ROE 51.2%
ROA 42.4%
FCF Margin 6.6%

Balance Sheet & Liquidity

Current Ratio
N/A
Quick Ratio
N/A
Debt/Equity
0.00x
Debt/Assets
17.2%
Interest Coverage
1,946.04x
Long-term Debt
N/A
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-03-21T00:54:11.474599 | Data as of: 2025-09-30 | Powered by Claude AI